PT Industri Jamu dan Farmasi Sido Muncul Tbk operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PT Industri Jamu dan Farmasi Sido Muncul Tbk with three other
pharmaceutical manufacturers in Asia:
Huaren Pharmaceutical Co Ltd
sales of 1.46 billion Chinese Renmimbi [US$216.43 million]
of which 91%
was Medicine Industry),
Tibet Cheezheng Tibetan Medicine Co Ltd
(1.40 billion Chinese Renmimbi [US$207.65 million]
of which 100%
was Drug), and
Qianjiang Yongan Pharmaceutical Co Ltd
based in CHINA
(1.37 billion Chinese Renmimbi [US$202.88 million]
of which 50%
PT Industri Jamu dan Farmasi Sido Muncul Tbk reported sales of 3.07 trillion Indonesian Rupiahs (US$206.75 million)
December of 2019.
increase of 11.0%
versus 2018, when the company's sales were 2.76 trillion Indonesian Rupiahs .
Sales at PT Industri Jamu dan Farmasi Sido Muncul Tbk have increased during each of the previous five years
(and since 2014, sales have increased a total of 40%).
Sales of Pharmacy saw an increase
17.0% in 2019, from
100.18 billion Indonesian Rupiahs to 117.25 billion Indonesian Rupiahs .